Alliar

Alliar is a leading Brazilian healthcare company specializing in diagnostic imaging and clinical analysis services. Established in 2011 through the merger of several prominent regional laboratories, the company has grown into one of the largest diagnostic networks in Brazil. Its service portfolio includes high-complexity exams such as Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and nuclear medicine, alongside traditional clinical pathology. Alliar operates under various brands, including CDB (Centro de Diagnósticos Brasil), and maintains a significant presence across numerous Brazilian states. The company is publicly traded on the B3 exchange and was recently acquired by the Fonte de Saúde investment fund, marking a new phase of strategic restructuring and expansion.